Wierzbicki, A S <br/><br/>
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias.  [electronic resource] 

 -  QJM : monthly journal of the Association of Physicians  Jul 1999 
 - 387-94 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1460-2725 
<br/><br/><label>Standard No.: </label>10.1093/qjmed/92.7.387  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--administration & dosage<br/>Atorvastatin<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Drug Administration Schedule<br/>Female<br/>Fibrinogen--analysis<br/>Heptanoic Acids--administration & dosage<br/>Humans<br/>Hyperlipidemia, Familial Combined--blood<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Pyrroles--administration & dosage<br/>Rhabdomyolysis--chemically induced<br/>Simvastatin--therapeutic use<br/>Triglycerides--blood